These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29731867)

  • 1. Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis.
    Qian H; Chen Y; Huang T; Liu T; Li X; Jiang G; Zhang W; Cheng S; Li P
    Oncol Lett; 2018 May; 15(5):6931-6940. PubMed ID: 29731867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
    Qian H; Huang T; Chen Y; Li X; Gong W; Jiang G; Zhang W; Cheng S; Li X; Li P
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S648-S655. PubMed ID: 30249882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells.
    Jiang L; Hao JL; Jin ML; Zhang YG; Wei P
    Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines.
    Teng JW; Hung E; Wu JM; Liang YH; Chiu YH; Tyan YS; Wang HS
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1297-1305. PubMed ID: 37116152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
    Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
    Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells.
    Yang S; Li SS; Yang XM; Yin DH; Wang L
    Oncol Lett; 2016 Jun; 11(6):4167-4176. PubMed ID: 27313761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
    Siegelin MD; Gaiser T; Siegelin Y
    Neurochem Int; 2009 Nov; 55(6):423-30. PubMed ID: 19409438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.
    Wehrkamp CJ; Gutwein AR; Natarajan SK; Phillippi MA; Mott JL
    PLoS One; 2014; 9(3):e90238. PubMed ID: 24603802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
    Fu X; Pang X; Qi H; Chen S; Li Y; Tan W
    Clin Transl Oncol; 2016 Mar; 18(3):277-82. PubMed ID: 26209051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Toxicol Lett; 2013 Aug; 221(3):197-204. PubMed ID: 23830991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergistic induction of apoptosis by the combination of TRAIL and low dose adriamycin in human osteosarcoma cell line U2OS].
    Yang DS; Miao XD; Ye ZM; Xu YS
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):595-7. PubMed ID: 16438867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between TRAIL and caspase-8 expression and their relationship with cell proliferation and apoptosis in human osteosarcoma.
    Ning X; Shang XW; Zhuang Y; Liu M; Yang H; Zhang H; Huang MZ
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of TRAF6 on proliferation, apoptosis and invasion in osteosarcoma are regulated by miR-124.
    Meng Q; Zhang W; Xu X; Li J; Mu H; Liu X; Qin L; Zhu X; Zheng M
    Int J Mol Med; 2018 May; 41(5):2968-2976. PubMed ID: 29436576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Sun J; Yu X; Wang C; Yu C; Li Z; Nie W; Xu X; Miao X; Jin X
    Med Sci Monit; 2017 Mar; 23():1190-1199. PubMed ID: 28270653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
    Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
    Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
    Jiang HN; Liu ZG; Hu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
    Shi RX; Ong CN; Shen HM
    Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
    Mirandola P; Sponzilli I; Gobbi G; Marmiroli S; Rinaldi L; Binazzi R; Piccari GG; Ramazzotti G; Gaboardi GC; Cocco L; Vitale M
    Int J Oncol; 2006 Jan; 28(1):127-33. PubMed ID: 16327988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.